Search Results
Results found for "GPCR Therapeutics"
- Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its...
ligands "The CX3C chemokine receptor 1 (CX3CR1), a member of the class A of G Protein-Coupled Receptors (GPCR patterns that characterize a functional state to contribute to the understanding of the complexity of the GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the...
harbored in the ADGLR3-hormone receptor domain (HRM, a common extracellular domain of the secretin-like GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent Read more at the source #DrGPCR #GPCR #IndustryNews
- Helix 8 in chemotactic receptors of the complement system
crystal structures of inactive C5aR1 in terms of an inverted orientation of helix H8, unobserved in other GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
The C5aR1 is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that Read more at the source #DrGPCR #GPCR #IndustryNews
- Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or sy
hypoglycemia, we first checked expression of counterregulatory hormone G-protein coupled receptors (GPCRs regulators and downstream enzymes catalyzing glycogen metabolism, gluconeogenesis and lipolysis by qPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- From Student to Mentor: What Alessandro Nicoli Learned About Leading in Science
As the lab grew, so did his responsibilities: from building computational models of GPCRs to guiding Join the GPCR scientist network and connect with peers shaping the next wave of discovery. ________ Keyword Cloud: #Mentoring #ScienceLeadership #PhDmentorship #GPCR #PhDlife #AcademicLeadership #LabCulture
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
indicated that the mechanism of KXS in treating depression was involved in the biological process of GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...
STING-YAP signaling by both a small-molecule STING agonist, SR-717, and a G protein-coupled receptor (GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- 4GPCRnet, September 26-29, 2022. Leipzig, Germany
August 2022 "WELCOME 4GPCRnet meeting bringing together four of the biggest GPCR networks in Europe for Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure of the human galanin receptor 2 bound to galanin and Gq reveals the basis of ligand...
Three G-protein coupled receptors (GPCRs) for galanin have been discovered, which is the focus of efforts Read more at the source #DrGPCR #GPCR #IndustryNews
- RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα
Signaling 7 (RGS7) in hyperlipidemia-dependent hepatic dysfunction. " Read more at the source #DrGPCR #GPCR
- Protein Uncoupling as an Innovative Practice in Diabetes Mellitus Treatment: A Metabolic Disorder
Read more at the source #DrGPCR #GPCR #IndustryNews
- Identification and functional characterization of the sulfakinin and sulfakinin receptor in the...
physiological functions in invertebrates through the interaction with G-protein-coupled receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
FRANCISCO & SHANGHAI- ShouTi Inc., a clinical-stage global biopharmaceutical company developing novel oral therapeutics Read more at the source #DrGPCR #GPCR #IndustryNews
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
These can be used either as stand-alone therapeutics or to improve the safety profile of opioid drugs Read more at the source #DrGPCR #GPCR #IndustryNews
- Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal
Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs), today announced that it will be presenting important Vice-President Drug Discovery, will present Orion’s novel technology for targeting undrugged peptidergic GPCRs discovery platform, one of the fastest drug discovery solutions in the industry for targeting peptidergic GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Delineation of GPR15 receptor-mediated Gα protein signaling profile in recombinant mammalian cell
September 2022 "The GPR15 receptor is a G protein-coupled receptor (GPCR), which is activated by an endogenous Read more at the source #DrGPCR #GPCR #IndustryNews
- Novo Nordisk moves to strengthen obesity efforts
Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Therapeutics Read more at the source #DrGPCR #GPCR #IndustryNews
- FSH and bone: Comparison between males with central versus primary hypogonadism
Read more at the source #DrGPCR #GPCR #IndustryNews
- Discovery On Target, October 17-20, 2022, Boston, USA
and technologies, as well as target validation strategies for the discovery and development of novel therapeutic Read more at the source #DrGPCR #GPCR #IndustryNews
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute Read more at the source #DrGPCR #GPCR #IndustryNews
- Learn more about Neurocrine Biosciences with their new video
Read more at the source #DrGPCR #GPCR #IndustryNews
- Drug Discovery Picks Up the Pace, Stays on Target
drug efficacy analyses, and toxicity studies; technologies that stabilize G protein–coupled receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Ginsenoside Rg5 allosterically interacts with P2RY12 and ameliorates deep venous thrombosis by...
Read more at the source #DrGPCR #GPCR #IndustryNews
- TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory...
The expression markers related to odontoblastic differentiation of hDPSCs were observed by qPCR and chemical The G protein and intracellular Ca2+ were detected, respectively, by qPCR and Fluo-4AM Ca2+ fluorescent Read more at the source #DrGPCR #GPCR #IndustryNews
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
adipose tissue size more effectively than exendin, suggesting that biased agonism can lead to distinct therapeutic In conclusion, biased agonism at the GLP-1R represents a promising strategy for optimizing therapeutic continues to grow, it is likely to play an increasingly important role in the design of next-generation therapeutics Christopoulos, Signalling bias in new drug discovery: detection, quantification and therapeutic impact Drucker, D.J., Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Â
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics Read more at the source #DrGPCR #GPCR #IndustryNews
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
The identification of unified innate threat pathways may provide insights into developing therapeutic Read more at the source #DrGPCR #GPCR #IndustryNews

